These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 20196723)

  • 1. Tumor markers: the potential of "omics" approach.
    Sikaroodi M; Galachiantz Y; Baranova A
    Curr Mol Med; 2010 Mar; 10(2):249-57. PubMed ID: 20196723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer proteomics: Serum diagnostics for tumor marker discovery.
    Rai AJ; Chan DW
    Ann N Y Acad Sci; 2004 Jun; 1022():286-94. PubMed ID: 15251974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular profiling of human cancer: new opportunities.
    Englert CR; Petricoin EF; Krizman DB; Emmert-Buck MR
    Curr Opin Mol Ther; 1999 Dec; 1(6):712-9. PubMed ID: 19629868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective.
    Findeisen P; Neumaier M
    Clin Chem Lab Med; 2009; 47(6):666-84. PubMed ID: 19445650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics in cancer screening and management in gynecologic cancer.
    Hu W; Wu W; Kobayashi R; Kavanagh JJ
    Curr Oncol Rep; 2004 Nov; 6(6):456-62. PubMed ID: 15485615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of renal cell carcinoma-associated markers via proteome- and other 'ome'-based analyses.
    Seliger B; Lichtenfels R; Kellner R
    Brief Funct Genomic Proteomic; 2003 Oct; 2(3):194-212. PubMed ID: 15239923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiling: monitoring transcription and translation products using DNA microarrays and proteomics.
    Celis JE; Kruhøffer M; Gromova I; Frederiksen C; Ostergaard M; Thykjaer T; Gromov P; Yu J; Pálsdóttir H; Magnusson N; Orntoft TF
    FEBS Lett; 2000 Aug; 480(1):2-16. PubMed ID: 10967322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics: a new approach to the study of disease.
    Chambers G; Lawrie L; Cash P; Murray GI
    J Pathol; 2000 Nov; 192(3):280-8. PubMed ID: 11054709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatics for cancer management in the post-genome era.
    Katoh M; Katoh M
    Technol Cancer Res Treat; 2006 Apr; 5(2):169-75. PubMed ID: 16551136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomics and islet research.
    Ahmed M
    Adv Exp Med Biol; 2010; 654():363-90. PubMed ID: 20217506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiling signatures of ovarian cancer tumour suppression using 2D-DIGE and 2D-LC-MS/MS with tandem mass tagging.
    Sinclair J; Metodieva G; Dafou D; Gayther SA; Timms JF
    J Proteomics; 2011 Apr; 74(4):451-65. PubMed ID: 21237297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer proteomics.
    Tan HT; Lee YH; Chung MC
    Mass Spectrom Rev; 2012; 31(5):583-605. PubMed ID: 22422534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral response to cancer as a tool for biomarker discovery.
    Desmetz C; Cortijo C; Mangé A; Solassol J
    J Proteomics; 2009 Aug; 72(6):982-8. PubMed ID: 19539066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic approaches to the diagnosis, treatment, and monitoring of cancer.
    Wulfkuhle JD; Paweletz CP; Steeg PS; Petricoin EF; Liotta L
    Adv Exp Med Biol; 2003; 532():59-68. PubMed ID: 12908550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ongoing evolution of proteomics in malignancy.
    Dhamoon AS; Kohn EC; Azad NS
    Drug Discov Today; 2007 Sep; 12(17-18):700-8. PubMed ID: 17826682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteome profiling of breast tumors by gel electrophoresis and nanoscale electrospray ionization mass spectrometry.
    Alldridge L; Metodieva G; Greenwood C; Al-Janabi K; Thwaites L; Sauven P; Metodiev M
    J Proteome Res; 2008 Apr; 7(4):1458-69. PubMed ID: 18257521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Workshop on cancer biometrics: identifying biomarkers and surrogates of cancer in patients: a meeting held at the Masur Auditorium, National Institutes of Health.
    Lotze MT; Wang E; Marincola FM; Hanna N; Bugelski PJ; Burns CA; Coukos G; Damle N; Godfrey TE; Howell WM; Panelli MC; Perricone MA; Petricoin EF; Sauter G; Scheibenbogen C; Shivers SC; Taylor DL; Weinstein JN; Whiteside TL
    J Immunother; 2005; 28(2):79-119. PubMed ID: 15725954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From the genome to the proteome--biomarkers in colorectal cancer.
    Habermann JK; Bader FG; Franke C; Zimmermann K; Gemoll T; Fritzsche B; Ried T; Auer G; Bruch HP; Roblick UJ
    Langenbecks Arch Surg; 2008 Jan; 393(1):93-104. PubMed ID: 17938952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue and serum proteomic profiling for diagnostic and prognostic bladder cancer biomarkers.
    Schwamborn K; Gaisa NT; Henkel C
    Expert Rev Proteomics; 2010 Dec; 7(6):897-906. PubMed ID: 21142890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optomechanical devices for deep plasma cancer proteomics.
    Kosaka PM; Calleja M; Tamayo J
    Semin Cancer Biol; 2018 Oct; 52(Pt 1):26-38. PubMed ID: 28867489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.